NEPH Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
6.0M
+15.4%
5.2M
+10.2%
4.7M
-0.7%
4.8M
+7.8%
4.4M
Cost of Revenue
2.0M
-10.3%
2.2M
+12.8%
2.0M
+6.4%
1.8M
+13.9%
1.6M
Gross Profit
4.0M
+34.5%
3.0M
+8.4%
2.8M
-5.3%
2.9M
+4.3%
2.8M
Operating Expenses
2.8M
-2.9%
2.9M
+5.6%
2.7M
+5.5%
2.6M
+2.1%
2.5M
R&D
366.0K
+5.8%
346.0K
-12.4%
395.0K
+16.9%
338.0K
+8.7%
311.0K
SG&A
2.4M
-4.1%
2.5M
+8.9%
2.3M
+3.9%
2.2M
+1.3%
2.2M
Operating Income
1.2M
+1150.5%
97.0K
+438.9%
18.0K
-94.3%
314.0K
+26.6%
248.0K
EBITDA
1.2M
+900.8%
124.0K
+148.0%
50.0K
-85.6%
348.0K
+23.8%
281.0K
Net Income
1.2M
+755.0%
140.0K
+125.8%
62.0K
-81.6%
337.0K
+42.2%
237.0K
EPS (Basic)
$0.11
+1000.0%
$0.01
+0.0%
$0.01
-66.7%
$0.03
+50.0%
$0.02
EPS (Diluted)
$0.11
+1000.0%
$0.01
+0.0%
$0.01
-66.7%
$0.03
+50.0%
$0.02
Shares (Diluted)
11.1M
+1.1%
11.0M
-3.6%
11.4M
+3.3%
11.0M
+2.1%
10.8M
Nephros (NEPH) โ€” Financials